Kobo Biotech Limited (BOM:531541)
2.720
+0.010 (0.37%)
At close: May 19, 2025
Kobo Biotech Statistics
Total Valuation
Kobo Biotech has a market cap or net worth of INR 70.05 million. The enterprise value is 1.47 billion.
Market Cap | 70.05M |
Enterprise Value | 1.47B |
Important Dates
The next estimated earnings date is Friday, May 30, 2025.
Earnings Date | May 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Kobo Biotech has 23.83 million shares outstanding. The number of shares has decreased by -0.80% in one year.
Current Share Class | 23.83M |
Shares Outstanding | 23.83M |
Shares Change (YoY) | -0.80% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 2.16% |
Owned by Institutions (%) | n/a |
Float | 12.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.05 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -29.11 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -50,566.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -33.91% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -103,979 |
Employee Count | 484 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.63% in the last 52 weeks. The beta is 0.36, so Kobo Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.36 |
52-Week Price Change | -41.63% |
50-Day Moving Average | 2.88 |
200-Day Moving Average | 3.17 |
Relative Strength Index (RSI) | 49.92 |
Average Volume (20 Days) | 4,222 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -50.57M |
Pretax Income | -50.33M |
Net Income | -50.33M |
EBITDA | -9.83M |
EBIT | -50.57M |
Earnings Per Share (EPS) | -2.12 |
Balance Sheet
The company has 1.81 million in cash and 1.40 billion in debt, giving a net cash position of -1.40 billion or -58.56 per share.
Cash & Cash Equivalents | 1.81M |
Total Debt | 1.40B |
Net Cash | -1.40B |
Net Cash Per Share | -58.56 |
Equity (Book Value) | -1.33B |
Book Value Per Share | -55.79 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Kobo Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.80% |
Shareholder Yield | n/a |
Earnings Yield | -71.85% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |